[go: up one dir, main page]

TN2009000512A1 - Modifying glycoprotein production in plants - Google Patents

Modifying glycoprotein production in plants

Info

Publication number
TN2009000512A1
TN2009000512A1 TNP2009000512A TN2009000512A TN2009000512A1 TN 2009000512 A1 TN2009000512 A1 TN 2009000512A1 TN P2009000512 A TNP2009000512 A TN P2009000512A TN 2009000512 A TN2009000512 A TN 2009000512A TN 2009000512 A1 TN2009000512 A1 TN 2009000512A1
Authority
TN
Tunisia
Prior art keywords
plant
nucleotide sequence
protein
interest
plants
Prior art date
Application number
TNP2009000512A
Other languages
English (en)
Inventor
Aoust Marc-Andre D
Estelle Marquet-Blouin
Muriel Bardor
Carole Burel
Loic Faye
Patrice Lerouge
Louis-Philippe Vezina
Véronique Gomord
Stéphanie Aquin
Christophe Rihouey
Thomas Paccalet
Christophe Sourrouille
Original Assignee
Centre Nat Rech Scient
Medicago Inc
Univ Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Medicago Inc, Univ Rouen filed Critical Centre Nat Rech Scient
Publication of TN2009000512A1 publication Critical patent/TN2009000512A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Cultivation Of Plants (AREA)
TNP2009000512A 2007-06-15 2009-12-10 Modifying glycoprotein production in plants TN2009000512A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94434407P 2007-06-15 2007-06-15
PCT/CA2008/001139 WO2008151440A1 (fr) 2007-06-15 2008-06-13 Modification de la production de glycoprotéine dans des plantes

Publications (1)

Publication Number Publication Date
TN2009000512A1 true TN2009000512A1 (en) 2011-03-31

Family

ID=40129187

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000512A TN2009000512A1 (en) 2007-06-15 2009-12-10 Modifying glycoprotein production in plants

Country Status (24)

Country Link
US (1) US20110008837A1 (fr)
EP (1) EP2155880B1 (fr)
JP (1) JP5783720B2 (fr)
KR (2) KR101385050B1 (fr)
CN (3) CN104962579A (fr)
AU (1) AU2008261527C1 (fr)
BR (1) BRPI0812538B1 (fr)
CA (2) CA2795379A1 (fr)
DK (1) DK2155880T3 (fr)
EG (1) EG26600A (fr)
ES (1) ES2624776T3 (fr)
HU (1) HUE031698T2 (fr)
IL (1) IL202568A (fr)
MA (1) MA31516B1 (fr)
MX (1) MX2009013665A (fr)
NZ (2) NZ598417A (fr)
PL (1) PL2155880T3 (fr)
PT (1) PT2155880T (fr)
RU (2) RU2499053C2 (fr)
SG (1) SG185249A1 (fr)
SI (1) SI2155880T1 (fr)
TN (1) TN2009000512A1 (fr)
WO (1) WO2008151440A1 (fr)
ZA (1) ZA201000207B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009202819B2 (en) 2007-07-13 2014-08-28 Aramis Biotechnologies Inc. Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin
CA2615372A1 (fr) 2007-07-13 2009-01-13 Marc-Andre D'aoust Particules semblables au virus grippal a comprenant de l'hemagglutinine
JP5809054B2 (ja) 2008-07-08 2015-11-10 メディカゴ インコーポレイテッド 可溶性組換えインフルエンザ抗原
EP2318530B1 (fr) 2008-07-18 2016-06-22 Medicago Inc. Nouvel épitope d immunisation contre l'influenzavirus
HUE039100T2 (hu) 2009-06-24 2018-12-28 Medicago Inc Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék
MY158475A (en) 2009-09-22 2016-10-14 Medicago Inc Method of preparing plant-derived proteins
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
US11673926B2 (en) * 2011-06-07 2023-06-13 Ibio, Inc. In vivo de-glycosylation of recombinant proteins by co-expression with PNGase F
US9181532B2 (en) 2011-07-29 2015-11-10 Icon Genetics Gmbh Production of galactosylated N-glycans in plants
FI2760882T3 (fi) 2011-09-30 2023-07-17 Medicago Inc Viruksen kaltaisen partikkelin saantojen lisääminen kasveissa
WO2013169009A1 (fr) * 2012-05-08 2013-11-14 경상대학교 산학협력단 Plante pour la production de n-glycane riche en mannose, et procédé de production de n-glycane riche en mannose à l'aide de celle-ci
IL295155A (en) 2013-03-28 2022-09-01 Medicago Inc Production of influenza virus-like particles in plants
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
ES2787042T3 (es) 2014-07-11 2020-10-14 Medicago Inc Modificación de la producción de proteínas en plantas
CN107810271B (zh) * 2014-11-20 2021-09-28 耶路撒冷希伯来大学伊萨姆研发公司 用于在植物细胞中生产具有改变的糖基化模式的多肽的组合物和方法
WO2018098572A1 (fr) 2016-12-01 2018-06-07 Plantform Corporation Plante transgénique à activité fucosyltransférase et xylosyltransférase réduite
CN111328347A (zh) * 2017-09-11 2020-06-23 R.J.雷诺兹烟草公司 通过与p21共表达来增加植物中感兴趣基因的表达的方法和组合物
JP7566045B2 (ja) * 2021-01-15 2024-10-11 デンカ株式会社 栽培条件を決定する方法、及び目的タンパク質又は目的ペプチドの製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312746A (en) * 1993-01-08 1994-05-17 Life Technologies, Inc. Cloning and expressing restriction endonucleases and modification methylases from caryophanon
GB9524350D0 (en) * 1995-11-29 1996-01-31 Lynxvale Ltd Enhancer-increased gene expression in plants
US5945326A (en) * 1997-03-20 1999-08-31 New England Biolabs, Inc. Method for cloning and producing the Spel restriction endonuclease
JP2002543760A (ja) * 1998-12-09 2002-12-24 達治 関 ヒト型糖鎖をもつ糖タンパク質の生産方法
US7125978B1 (en) * 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
WO2001025455A2 (fr) * 1999-10-04 2001-04-12 Medicago Inc. Promoteur destine a reguler l'expression de genes etrangers
AU1573601A (en) * 1999-10-21 2001-04-30 Monsanto Company Post-translational modification of recombinant proteins produced in plants
ES2349427T3 (es) * 1999-10-26 2011-01-03 Stichting Dienst Landbouwkundig Onderzoek Glicosilación de tipo mamífero en plantas.
CA2925231A1 (fr) * 1999-10-26 2001-05-03 Stichting Dienst Landbouwkundig Onderzoek Glycosylation de type mammifere dans des plantes transgeniques par l'expression de galactosyltrasferases et de sialyl transferases
JP2005505234A (ja) * 2001-01-19 2005-02-24 ザ ダウ ケミカル カンパニー 植物細胞によるヒト型糖鎖をもつ糖タンパク質の分泌生産方法
US20030035774A1 (en) 2001-07-18 2003-02-20 Adjei Akwete L. Salt/ion pair medicinal aerosol formulation
NZ571596A (en) * 2001-08-03 2010-11-26 Glycart Biotechnology Ag Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
AU2003219745B8 (en) * 2002-02-13 2008-10-09 Wisconsin Alumni Research Foundation Signal for packaging of influenza virus vectors
AU2003219418B2 (en) * 2002-03-19 2008-02-28 Stichting Dienst Landbouwkundig Onderzoek Optimizing glycan processing in plants
JP5350573B2 (ja) * 2002-03-19 2013-11-27 スティヒティング ディーンスト ランドバウクンディフ オンデルズーク 植物におけるgntiii発現
PL224787B1 (pl) 2003-01-22 2017-01-31 Roche Glycart Ag Wyizolowany kwas nukleinowy, ssaczy wektor ekspresyjny, fuzje polipeptydowe, komórki gospodarza, sposób wytwarzania fuzji polipeptydowych, sposoby in vitro i ex vivo modyfikowania profilu glikozylacji, wyizolowana cząsteczka kwasu nukleinowego
CN1761746B (zh) * 2003-01-22 2016-03-23 罗氏格黎卡特股份公司 融合构建体及其用来生产Fc受体结合亲和性和效应子功能提高的抗体的用途
BRPI0410340A (pt) * 2003-05-05 2006-05-30 Dow Agrosciences Llc vetores e células para preparar composições imunoprotetoras derivadas de plantas transgênicas
JP2006212019A (ja) * 2004-04-30 2006-08-17 National Institute Of Agrobiological Sciences 植物を用いたユビキノン−10の製造方法

Also Published As

Publication number Publication date
PT2155880T (pt) 2016-11-18
JP2010531136A (ja) 2010-09-24
ZA201000207B (en) 2013-09-25
CN104962579A (zh) 2015-10-07
AU2008261527B2 (en) 2014-04-10
NZ598417A (en) 2013-06-28
MX2009013665A (es) 2010-06-02
AU2008261527B8 (en) 2014-04-24
WO2008151440A1 (fr) 2008-12-18
CN103382487A (zh) 2013-11-06
EP2155880B1 (fr) 2016-08-10
MA31516B1 (fr) 2010-07-01
EG26600A (en) 2014-03-23
SG185249A1 (en) 2012-11-29
KR101385050B1 (ko) 2014-05-13
IL202568A0 (en) 2011-08-01
NZ581944A (en) 2012-03-30
PL2155880T3 (pl) 2017-06-30
CN101918559A (zh) 2010-12-15
AU2008261527A8 (en) 2010-01-21
CA2700180C (fr) 2013-01-29
AU2008261527A1 (en) 2008-12-18
SI2155880T1 (sl) 2017-03-31
EP2155880A4 (fr) 2010-08-04
CA2700180A1 (fr) 2008-12-18
RU2010101024A (ru) 2011-07-20
BRPI0812538A2 (pt) 2014-09-30
US20110008837A1 (en) 2011-01-13
CA2795379A1 (fr) 2008-12-18
BRPI0812538B1 (pt) 2021-03-16
RU2499053C2 (ru) 2013-11-20
KR20130075787A (ko) 2013-07-05
ES2624776T3 (es) 2017-07-17
JP5783720B2 (ja) 2015-09-24
HUE031698T2 (en) 2017-07-28
EP2155880A1 (fr) 2010-02-24
WO2008151440A8 (fr) 2010-03-04
KR20100037602A (ko) 2010-04-09
DK2155880T3 (en) 2016-12-05
AU2008261527C1 (en) 2014-09-04
IL202568A (en) 2015-02-26
RU2013137208A (ru) 2015-02-20
WO2008151440A4 (fr) 2009-02-26

Similar Documents

Publication Publication Date Title
TN2009000512A1 (en) Modifying glycoprotein production in plants
PH12012500816A1 (en) Modified oil encapsulating proteins and uses thereof
SG10201803982TA (en) Antibodies and processes for preparing the same
MY160680A (en) Process for producing molecules containing specialized glycan structures
DE60022313D1 (de) Alternansucrase-kodierende nukleinsäure moleküle
DE50014279D1 (de) Nukleinsäuremoleküle aus pflanzen codierend enzyme, die an der stärkesynthese beteiligt sind
AR048024A1 (es) Plantas con actividad aumentada de distintas enzimas fosforilantes del almidon
MX2009009371A (es) Produccion mejorada de derivados de acidos grasos.
MX2009011751A (es) Produccion de proteinas de alto contenido de manosa en cultivo de plantas.
WO2008132314A3 (fr) Procede de synthese de nanoparticules metalliques cubiques en presence de deux reducteurs
DK1725666T3 (da) Planter med reduceret aktivitet for stivelsesphosphoryleringsenzymet phosphoglucan-vand-dikinase
WO2011100477A3 (fr) Anticorps et procédés de préparation de ceux-ci
CY1109471T1 (el) Μεθοδοι και μεσα για την παραγωγη υαλουρονανης
WO2009080743A3 (fr) Plantes à rendement accru (ko nue)
WO2010066411A3 (fr) Polypeptides à activité de cellobiohydrolase ii
MX2009010867A (es) Plantas con caracteristicas de crecimientos mejoradas en condiciones de disponibilidad reducida de nutrientes y un metodo para producirlas.
IN2012DN01454A (fr)
EP2162537A4 (fr) Utilisation d'organismes genetiquement modifies pour generer des enzymes de decomposition de biomasse
WO2006079546A3 (fr) Production de protéines hétéro-oligomères dans des plantes
WO2007134268A3 (fr) Production de biohydrogène par voie enzymatique artificielle
GB2458419A (en) Vector for expressing NC protein of HIV and method for producing NC protein using the same
WO2008033556A3 (fr) Traitement de protéines sous haute pression permettant de réduire leur immunogénicité
WO2007140340A3 (fr) Formation de réseaux vasculaires à l'aide de cellules souches embryonnaires
WO2009137146A3 (fr) Procédé de production de lignées cellulaires continues
PL1861504T3 (pl) Glikoinżynieria grzybów